Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?

scientific article published in July 2009

Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MUS.21304
P698PubMed publication ID19533640

P50authorStefano BastianelloQ42327537
Alfredo CostaQ42893766
P2093author name stringG Germani
C Danesino
A Moglia
A Pichiecchio
S Ravaglia
M Ponzio
A Repetto
D Maranzana
E Tavazzi
G U Poloni
P433issue1
P921main subjectenzyme replacement therapyQ916766
P304page(s)122-125
P577publication date2009-07-01
P1433published inMuscle and NerveQ15764281
P1476titleEnzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?
P478volume40

Reverse relations

cites work (P2860)
Q37976637Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques
Q84390466Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset type II glycogenosis?
Q43160797Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis
Q51771787Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response.
Q36319212Combined quantification of fatty infiltration, T 1-relaxation times and T 2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients
Q36154874Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.
Q31052050Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy
Q38784024Muscle imaging in inherited and acquired muscle diseases
Q34130501Neuromuscular imaging in inherited muscle diseases
Q36953239Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Q36907450Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
Q51236198Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease.
Q57642652Whole-body muscle MRI to detect myopathies in non-extrapyramidal bent spine syndrome

Search more.